• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾显著增厚肢端雀斑样黑素瘤的临床病理特征和预后。

Clinicopathological characteristics and prognosis in significantly thick acral lentiginous melanoma in Taiwan.

机构信息

Department of Medical Education, National Taiwan University Hospital, Taipei, Taiwan.

Department of Surgery, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan.

出版信息

J Formos Med Assoc. 2022 Nov;121(11):2338-2344. doi: 10.1016/j.jfma.2021.12.001. Epub 2021 Dec 25.

DOI:10.1016/j.jfma.2021.12.001
PMID:34961669
Abstract

This retrospective cohort study enrolled 385 patients diagnosed with cutaneous melanoma from 1980 to 2021 in National Taiwan University Hospital (NTUH). The aim of this study was to investigate the relationship between thickness of primary melanoma lesions and disease outcome of melanoma patients, in particular, those diagnosed with acral lentiginous melanoma (ALM). The association between important clinicopathological characteristics other than tumor thickness and disease outcome was also analyzed. Survival analyses with the Kaplan-Meier method were utilized to investigate the prognoses of patients with different lesion thickness. The male-to-female ratio was 1.12:1. The median age at diagnosis was 63 years old (mean: 62.2 years). There were 283 cases (73.5%) of acral lentiginous melanoma (ALM) with a male-to-female ratio of 1.04:1. Between patients with primary ALM lesions 4.1 millimeters (mm) to 8.0 mm thick and those with lesions over 8.0 mm thick, significant differences in prognostic outcomes including incidence of second recurrences within 1 year (raw p = 0.003, Bonferroni corrected p = 0.009) and distant metastases within 1 year (raw p = 0.003, Bonferroni corrected p = 0.008), were observed. Significantly worse 1-year (raw p = 0.01, Bonferroni corrected p=0.03) and 2-year survival (raw p = 0.006, Bonferroni corrected p = 0.02) were found in ALM patients with lesions of over 8 mm thick than those with lesions 4.1 mm to 8.0 mm at diagnosis. Vigilant short-term follow-up is warranted in ALM patients with lesions of over 8.0 mm thick at diagnosis due to higher risks of adverse outcome.

摘要

这项回顾性队列研究纳入了 1980 年至 2021 年期间在国立台湾大学医院(NTUH)诊断为皮肤黑色素瘤的 385 名患者。本研究旨在探讨原发性黑色素瘤病变厚度与黑色素瘤患者疾病结局的关系,特别是肢端雀斑样黑色素瘤(ALM)患者。还分析了除肿瘤厚度以外的重要临床病理特征与疾病结局的关系。采用 Kaplan-Meier 方法进行生存分析,以探讨不同病变厚度患者的预后。患者的男女比例为 1.12:1。中位诊断年龄为 63 岁(平均:62.2 岁)。283 例(73.5%)为肢端雀斑样黑色素瘤(ALM),男女比例为 1.04:1。在原发性 ALM 病变厚度为 4.1 毫米(mm)至 8.0 毫米和病变厚度超过 8.0 毫米的患者之间,在预后结果方面存在显著差异,包括一年内第二次复发的发生率(原始 p=0.003,Bonferroni 校正后 p=0.009)和一年内远处转移的发生率(原始 p=0.003,Bonferroni 校正后 p=0.008)。在 ALM 患者中,病变厚度超过 8.0 毫米的患者 1 年(原始 p=0.01,Bonferroni 校正后 p=0.03)和 2 年(原始 p=0.006,Bonferroni 校正后 p=0.02)的生存率显著更差,与诊断时病变厚度为 4.1mm 至 8.0mm 的患者相比。由于病变厚度超过 8.0 毫米的 ALM 患者发生不良结局的风险较高,因此需要对其进行密切的短期随访。

相似文献

1
Clinicopathological characteristics and prognosis in significantly thick acral lentiginous melanoma in Taiwan.台湾显著增厚肢端雀斑样黑素瘤的临床病理特征和预后。
J Formos Med Assoc. 2022 Nov;121(11):2338-2344. doi: 10.1016/j.jfma.2021.12.001. Epub 2021 Dec 25.
2
Risk factors of recurrence and distant metastasis in primary cutaneous melanoma in Taiwan.台湾地区原发性皮肤黑色素瘤的复发和远处转移的风险因素。
Sci Rep. 2021 Oct 25;11(1):21012. doi: 10.1038/s41598-021-00386-4.
3
Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan.肢端雀斑样痣黑色素瘤与其他黑色素瘤:日本单中心分析
J Dermatol. 2017 Aug;44(8):932-938. doi: 10.1111/1346-8138.13834. Epub 2017 Mar 24.
4
Acral lentiginous melanoma: who benefits from sentinel lymph node biopsy?肢端黑色素瘤:谁受益于前哨淋巴结活检?
J Am Acad Dermatol. 2015 Jan;72(1):71-7. doi: 10.1016/j.jaad.2014.10.008. Epub 2014 Oct 28.
5
Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.肢端雀斑样痣黑色素瘤:1986 - 2005年美国的发病率及生存模式
Arch Dermatol. 2009 Apr;145(4):427-34. doi: 10.1001/archdermatol.2008.609.
6
Tumor infiltrating lymphocytes in acral lentiginous melanoma: a study of a large cohort of cases from Latin America.肢端黑色素瘤中的肿瘤浸润淋巴细胞:来自拉丁美洲的大样本队列研究。
Clin Transl Oncol. 2017 Dec;19(12):1478-1488. doi: 10.1007/s12094-017-1685-3. Epub 2017 Jun 2.
7
Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival.肢端雀斑样黑素瘤与某些预后不良的组织病理学因素相关,但可能与淋巴结受累、复发和更差的生存无关。
Pathobiology. 2018;85(4):227-231. doi: 10.1159/000488457. Epub 2018 Jun 1.
8
Malignant melanoma in Taiwan: a prognostic study of 181 cases.台湾地区的恶性黑色素瘤:181例病例的预后研究
Melanoma Res. 2004 Dec;14(6):537-41. doi: 10.1097/00008390-200412000-00016.
9
Acral Lentiginous Melanoma: Incidence and Survival in the United States, 2006-2015, an Analysis of the SEER Registry.肢端雀斑样痣黑色素瘤:2006 - 2015年美国的发病率与生存率,基于监测、流行病学和最终结果(SEER)数据库的分析
J Surg Res. 2020 Jul;251:329-339. doi: 10.1016/j.jss.2020.02.010. Epub 2020 Mar 21.
10
Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.肢端雀斑样痣黑色素瘤:126例临床预后研究
Br J Dermatol. 2006 Sep;155(3):561-9. doi: 10.1111/j.1365-2133.2006.07368.x.

引用本文的文献

1
Multivariate analysis and prediction model construction for distant metastasis of Acral Melanoma.肢端黑色素瘤远处转移的多因素分析及预测模型构建
Am J Cancer Res. 2025 Aug 25;15(8):3678-3692. doi: 10.62347/OLPB3585. eCollection 2025.
2
Clinical features, molecular pathology, and immune microenvironmental characteristics of acral melanoma.肢端黑素瘤的临床特征、分子病理学和免疫微环境特征。
J Transl Med. 2022 Aug 16;20(1):367. doi: 10.1186/s12967-022-03532-2.